Surgery Doctors in Easley, SC Accepting Medicare

7 Surgery doctors found. Showing 1 - 7

David Calhoun Jacobs Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 403 Hillcrest Dr Ste C, Easley, SC 29640 Phone: 864-855-1644

Dr. Steven Jeffrey Fass, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1653 E Main St, Easley, SC 29640 Phone: 864-306-8533    Fax: 864-306-8513

Joshua Alan Morowitz, MD Surgery - Vascular Surgery Medicare: Medicare Enrolled Practice Location: 403 Hillcrest Dr, Easley, SC 29640 Phone: 864-855-5104    Fax: 864-855-5880

Dr. Johnny H Cox, MD Surgery Medicare: Medicare Enrolled Practice Location: 403 Hillcrest Dr, Suite C, Easley, SC 29640 Phone: 864-855-1644

Elena Dimitrievna Brown, FIRST ASSISTANT Surgery - Vascular Surgery Medicare: Not Enrolled in Medicare Practice Location: 305 Lena Dr, Easley, SC 29640 Phone: 678-559-4988

Mackenzie J Bartz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 403 Hillcrest Dr Ste C, Easley, SC 29640 Phone: 864-855-1644    Fax: 864-855-6101

Dr. Rowena R Sim, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 403 C Hillcrest Dr, Palmetto Health Alliance, Easley, SC 29640 Phone: 864-855-1644    Fax: 864-855-6101

News Archive

Lung, kidney and cardiovascular issues are confirmed as complications of COVID-19

A new study published this month confirms the many complications of COVID-19 including cardiovascular, kidney, and lung complications.

METTLER TOLEDO introduces new semi-automated 96-channel liquid handling platform

METTLER TOLEDO proudly announces the launch of the Rainin BenchSmart 96, a new semi-automated 96-channel liquid handling platform. BenchSmart combines the speed and flexibility of a manual system with the precision and higher reliability of electronic pipetting.

Pluristem begins enrollment following FDA approval for clinical trials of its PLX-PAD stem cell product

Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced that it has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD, the Company's leading product candidate for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD).

Stem cells can repair damaged spinal tissue and help restore function in rats with spinal cord injuries

Each year, some 11,000 Americans sustain spinal cord injury, most often in traffic accidents. Costs of the condition approach $10 billion per year.

Read more Medical News

› Verified 5 days ago